Capital Analysts, LLC Sorrento Therapeutics, Inc. Transaction History

Capital Analysts, LLC

  • $2.45 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
$6.35 - $10.0 $3,175 - $5,000
-500 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$7.03 - $16.51 $3,515 - $8,255
500 New
500 $4,000
Q4 2020

Feb 16, 2021
SELL
$5.76 - $11.95 $8,640 - $17,925
-1,500 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$6.17 - $18.82 $9,255 - $28,230
1,500 New
1,500 $17,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email